Literature DB >> 6289282

Peptide influences on the development and regeneration of motor performance.

C Saint-Côme, G R Acker, F L Strand.   

Abstract

ACTH 1-39 (0.2 U IP daily for up to 18 days) has a beneficial effect on the functional reorganization of regenerating motor units of the extensor digitorum longus (EDL) in the adrenalectomized adult rat following crushing of the peroneal nerve. Motor unit activity (maximum twitch tension amplitude/mean increment in twitch tension as voltage is increased by 0.1 V gradations) and nerve-muscle efficiency (tetanic tension from indirect stimulation/tetanic tension from direct stimulation of EDL) were enhanced by ACTH 1-39. Other electrophysiological and contractile parameters were unaffected by the peptide. Spontaneous motor activity in cold stressed 13 day old rats was prolonged by Org 2766, a substituted analogue of ACTH/MSH 4-9, (0.1 microgram/kg daily) but unaffected by the same dosage of ACTH/MSH 4-10. The responsiveness of developing and regenerating motor systems to neuropeptides indicates a plasticity of neuronal connections, which depends on peptide sequence, dosage and the physiological state of the animal (normal, depressed, regenerating or developing, at rest or stressed).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289282     DOI: 10.1016/0196-9781(82)90105-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Characterization of MSH/ACTH-like immunoreactivity in sciatic nerves of Xenopus laevis by immunocytochemistry, western blotting and radioimmunoassay.

Authors:  J E Tingstedt; J B Nielsen; L I Larsson
Journal:  Histochemistry       Date:  1990

2.  ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation.

Authors:  Hasan Arrat; Thomas J Lukas; Teepu Siddique
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

3.  Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.

Authors:  Ritu Lal; Stacie Bell; Rashida Challenger; Vakessa Hammock; Mary Nyberg; Dima Decker; Patrice M Becker; David Young
Journal:  J Clin Pharmacol       Date:  2015-09-10       Impact factor: 3.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.